| Literature DB >> 15173195 |
Hiroshi Yonemura1, Takayuki Imamura, Kenji Soejima, Yo Nakahara, Wataru Morikawa, Yoshitaka Ushio, Yasuharu Kamachi, Hiroshi Nakatake, Keishin Sugawara, Tomohiro Nakagaki, Chikateru Nozaki.
Abstract
We have established a large-scale manufacturing system to produce recombinant human alpha-thrombin. In this system, a high yield of alpha-thrombin is prepared from prethrombin-2 activated by recombinant ecarin. We produced human prethrombin-2 using mouse myeloma cells and an expression plasmid carrying the chicken beta-actin promoter and mutant dihydrofolate reductase gene for gene amplification. To increase prethrombin-2 expression further, we performed fed-batch cultivation with the addition of vegetable peptone in 50 liters of suspension culture. After five feedings of vegetable peptone, the expression level of the recombinant prethrombin-2 reached 200 micro g/ml. Subsequently, the recombinant prethrombin-2 could be activated to alpha-thrombin by recombinant ecarin expressed in a similar manner. Finally, recombinant alpha-thrombin was purified to homogeneity by affinity chromatography using a benzamidine-Sepharose gel. The yield from prethrombin-2 in culture medium was approximately 70%. The activity of the purified recombinant alpha-thrombin, including hydrolysis of a chromogenic substrate, release of fibrinopeptide A, and activation of protein C, was indistinguishable from that of plasma-derived alpha-thrombin. Our system is suitable for the large-scale production of recombinant alpha-thrombin, which can be used in place of clinically available alpha-thrombin derived from human or bovine plasma.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15173195 DOI: 10.1093/jb/mvh070
Source DB: PubMed Journal: J Biochem ISSN: 0021-924X Impact factor: 3.387